ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome
Year: 2022
Type: conference-abstract
Source: Blood
Authors: Camilla K Lemvigh, Erin Michelle Parry, Stephanie L Deng, Nathan J Dangle, Neil Ruthen, Binyamin A. Knisbacher, Julien Broséus, Sébastien Hergalant, Romain Guieze, Shuqiang Li, Shanye Yin, Teddy Huang, Kenneth J Livak, Gad Getz, Donna S. Neuberg, Pierre Feugier, Peter Kharchenko, William G. Wierda, Lars Rønn Olsen, Nitin Jain, Catherine J. Wu
Institutions: Dana-Farber Cancer Institute, Technical University of Denmark, Harvard University, Broad Institute, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine, Université Clermont Auvergne, Centre Hospitalier Universitaire de Clermont-Ferrand, Clonal Heterogeneity, Leukemic environment, ThErapy Resistance of chronic leukemias, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310119393